Lineage Cell Therapeutics (AMEX:LCTX) is gearing up to announce its quarterly earnings on Thursday, 2026-03-05. Here’s a quick overview of what investors should know before the release.
Analysts are estimating that Lineage Cell Therapeutics will report an earnings per share (EPS) of $-0.05.
Investors in Lineage Cell Therapeutics are eagerly awaiting the company’s announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It’s worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Overview of Past Earnings
In the previous earnings release, the company missed EPS by $0.11, leading to a 1.73% increase in the share price the following trading session.
Here’s a look at Lineage Cell Therapeutics’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.02 | -0.02 | -0.03 | -0.03 |
| EPS Actual | -0.13 | -0.07 | -0.02 | -0.02 |
| Price Change % | 1.73 | 1.98 | -2.55 | 0.36 |
Performance of Lineage Cell Therapeutics Shares
Shares of Lineage Cell Therapeutics were trading at $1.89 as of March 03. Over the last 52-week period, shares are up 262.26%. Given that these returns are …